drugset / Trial / NCT00678457

Ondansetron With Olanzapine for the Treatment of Alcohol Dependence: A Preliminary Clinical Trial

NCT00678457

Phase 2 Completed 40 enrolled University of Virginia
RandomizedFactorialQuadruple-blindTreatment

Summary

This study would like to test whether the combination of ondansetron and olanzapine will be superior to placebo at decreasing self-reported heavy drinking among early onset alcoholics.

Timeline

Start
2007-01
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Olanzapine Small molecule 9 ug/kg
Subject Olanzapine Small molecule 18 ug/kg
Subject Olanzapine Small molecule 36 ug/kg
Subject Ondansetron Other / unclassified 4 ug/kg

Indications